Why Investors Liked Bionano Genomics' Q4 Results
The genomic analysis systems maker beat expectations and looks for a big jump in its installed base this year.
Bionano Genomics, Inc
The genomic analysis systems maker beat expectations and looks for a big jump in its installed base this year.
BNGO earnings call for the period ending December 31, 2020.
Yes...and no.
If you're bullish on genomics, you should be bullish on this stock.
The genetic testing specialist could access a major new market.
These high-flying stocks have been moneymakers since early November.
This high-flying stock is already one of the biggest winners in the new year.
Analysts are growing more bullish on the genetic testing specialist's growth potential.
A Wall Street analyst's target-price hike may have had something to do with it.
The biotech's stock sales are alarming investors.